has collaborator Lee, Ji-Hyun Director and Professor of Biostatistics, UNM Comprehensive Cancer Center
selected publications academic article Assessing Knowledge and Perceptions About Cancer Among American Indians of the Zuni Pueblo, NM.. Journal of cancer education : the official journal of the American Association for Cancer Education. :-. 2021 High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. 2017 Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.. Blood. 129:572-581. 2017 High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.. Leukemia. :-. 2017 Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.. Blood. 129:177-187. 2017 Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 2016 Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.. Nature communications. 7:-. 2016 Characterization of leukemias with ETV6-ABL1 fusion.. Haematologica. 101:1082-1093. 2016 Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.. ACS nano. :-. 2016 Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.. Cancer. 122:1017-1028. 2016 Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.. Cancer cell. 29:186-200. 2016 Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.. Blood. :-. 2015 Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.. Nature. 521:357-361. 2015 Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia.. Molecular cancer therapeutics. 14:364-374. 2015 A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 2015 Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.. Nature communications. 6:-. 2015 Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014 SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.. Blood. 121:148-155. 2013 Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.. Blood. 121:485-488. 2013 ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30:751-757. 2012 Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.. Blood. 120:833-842. 2012 Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.. Blood. 120:1473-1484. 2012 Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.. Advanced healthcare materials. 1:348-353. 2012 Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.. ACS nano. 6:2174-2188. 2012 Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.. Blood. 119:1872-1881. 2012 Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.. Cancer cell. 22:153-166. 2012 Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.. Blood. 120:4197-4204. 2012 Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.. Blood. 119:3512-3522. 2012 Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.. Blood. 120:3510-3518. 2012 Treatment-influenced associations of PML-RAR? mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.. Blood. 120:2098-2108. 2012 Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.. Nature genetics. 43:237-241. 2011 Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.. ACS nano. 5:5729-5745. 2011 Drug Repurposing from an Academic Perspective.. Drug discovery today. Therapeutic strategies. 8:61-69. 2011 Drug Repurposing from an Academic Perspective.. Drug discovery today. Therapeutic strategies. 8:61-69. 2011 Drug Repurposing from an Academic Perspective.. Drug discovery today. Therapeutic strategies. 8:61-69. 2011 GSI-I (Z-LLNle-CHO) inhibits ?-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.. Leukemia. 25:1135-1146. 2011 Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.. Blood. 118:3080-3087. 2011 The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.. Nature materials. 10:389-397. 2011 Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.. Blood. 116:3751-3757. 2010 Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.. Blood. 115:1394-1405. 2010 Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.. Blood. 116:4874-4884. 2010 Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.. Blood. 115:5312-5321. 2010 Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.. The New England journal of medicine. 360:470-480. 2009 Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.. JAMA. 301:393-403. 2009 Germline genomic variants associated with childhood acute lymphoblastic leukemia.. Nature genetics. 41:1001-1005. 2009 JAK mutations in high-risk childhood acute lymphoblastic leukemia.. Proceedings of the National Academy of Sciences of the United States of America. 106:9414-9418. 2009 Metnase mediates chromosome decatenation in acute leukemia cells.. Blood. 114:1852-1858. 2009 Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.. Nature genetics. 41:1243-1246. 2009 Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.. Pediatric blood & cancer. 53:1005-1010. 2009 Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26:4376-4384. 2008 Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 21:1341-1344. 2007 A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.. Nature medicine. 12:945-949. 2006 Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.. Blood. 108:685-696. 2006 Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method.. British journal of haematology. 135:358-361. 2006 Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.. Leukemia. 428-430. 2014 VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.. Leukemia. 216-220. 2014